1. Che X, Cai J, Liu Y, Xu T, Yang J, Wu C et al. Oxytocin signaling in the treatment of drug addiction: Therapeutic opportunities and challenges. Pharmacol Ther. 2021;223:107820. doi. 10.1016/j.pharmthera.2021.107820. [
DOI:10.1016/j.pharmthera.2021.107820] [
PMID]
2. Almutairi AMM. Principles of drug addiction treatment. Int J Med Dev Ctries. 2021;5(2):1523-7. doi.org/10.24911/IJMDC.51-1609883100. [
DOI:10.24911/IJMDC.51-1609883100]
3. Cao P, Zhang Z, Zhong J, Xu S, Huang Q, Fan N. Effects of treatment status and life quality on anxiety in MMT patients. Subst Abuse Treat Prev Policy. 2021;16:1-8. doi.org/10.1186/s13011-021-00343-4. [
DOI:10.1186/s13011-021-00343-4] [
PMID] [
PMCID]
4. Pourmohseni Koluri F, Haghshenas A, Asadi S. A comparison of brain-behavioral systems and gender differences among addicted and non-addicted persons. Adv Cogn Sci. 2011;13(2):9-22. Persian. http://icssjournal.ir/article-1-344-fa.html.
5. LaGrotta C. Gender differences in addiction. Curr Addict Rep. 2021;8:64-70. doi.10.1007/s40429-021-00355-x. [
DOI:10.1007/s40429-021-00355-x]
6. Agterberg S, Schubert N, Overington L, Corace K. Treatment barriers among individuals with co-occurring substance use and mental health problems: Examining gender differences. J Subst Abuse Treat. 2020; 112:29-35. doi. 10.1016/j.jsat.2020.01.005. [
DOI:10.1016/j.jsat.2020.01.005] [
PMID]
7. Gray JA, McNaughton N. The neuropsychology of anxiety: An enquiry in to the functions of the Septo-Hippocampal System. 2th ed. Oxford: Oxford University Press. 2003; 448p. https://global.oup.com/academic/product/the-neuropsychology-of-anxiety 9780198522713? cc=us&lang=en&. [
DOI:10.1093/acprof:oso/9780198522713.001.0001]
8. Franken IHA, Muris P. BIS/BAS personality characteristics and college students' substance use. Pers Individ Differ. 2006;40(7):1497-503. doi.org/10.1016/j.paid.2005.12.005. [
DOI:10.1016/j.paid.2005.12.005]
9. Bijtebier P, Beck I, Clase L, Vandereycken W. Grays' reinforcement sensitivity theory as a framework for research on personality-psychopathology association. Clin Psychol Rev. 2009;29(5):421-30. doi. 10.1016/j.cpr.2009.04.002. [
DOI:10.1016/j.cpr.2009.04.002] [
PMID]
10. Cahill CM, Lueptow L, Kim H, Shusharla R, Bishop A, Evans CJ et al. Kappa opioid signaling at the crossroads of chronic pain and opioid addiction. Handbook Exp Pharmacol. 2022;271:315-50. doi. 10.1007/164_2021_434. [
DOI:10.1007/164_2021_434] [
PMID]
11. Massaly N, Markovic T, Creed M, Al-Hasani R, Cahill CM, Moron JA. Pain, negative affective states and opioid-based analgesics: Safer pain therapies to dampen addiction. Inter Rev Neurobiol. 2021;157:31-68. doi. 10.1016/bs.irn.2020.09.002. [
DOI:10.1016/bs.irn.2020.09.002] [
PMID]
12. Khammarnia M, Peyvand M. The reasons of return to drug addiction and suggested solutions among the people referring to rehabilitation centers: A qualitative study. J Rafsanjan Univ Med Sci. 2018;17(6):523-38. Persian. http://journal.rums.ac.ir/article-1-4050-en.html
13. Akbaribooreng M, Dalakeh M, Saberi R, yasbelaghi B. The effectiveness of curriculums based on cognitive-behavioral therapy in the increase of self-efficacy and resilience among the addicts under methadone maintenance treatment. Res Addic. 2016;10(38):103-17. [Persian]. http://etiadpajohi.ir/article-1-639-fa.html.
14. Conner KM, Davidson JRT. Development of a new resilience scale: The Conner-Davidson Resilience Scale (CD - RISC). Depress Anxiety. 2003;18:76-82. [
DOI:10.1002/da.10113] [
PMID]
15. Croff JM, Beaman J. Family resilience and recovery from opioids and other addictions. Berlin: Springer. 2021. https://link.springer.com/book/10.1007/978-3-030-56958-7 [
DOI:10.1007/978-3-030-56958-7]
16. Sadeghi S, Fathi A. Developing a structural model of the role of social health on high-risk behaviors of young people mediated by resilience: social order. J Police Med. 2021;10(4):255-62. http://dx.doi.org/10.30505/10.4.255
17. Roozgard, F, Sadeghi, E. investigating the relationship between failure tolerance and resilience of parents of exceptional children. Third National Conference on Psychology, Education and Lifestyle. Qazvin, Iran. 2019. https://civilica.com/doc/1020834
18. Vasquez TES, McAuley RJ, Gupta NS, Koshy S, Marmol-Contreras Y, Green TA. Lever-press duration as a measure of frustration in sucrose and drug reinforcement. Psychopharmacol. 2021;238(4);959-68. doi.10.1007/s00213-020-05742-2. [
DOI:10.1007/s00213-020-05742-2] [
PMID] [
PMCID]
19. Hooshmandi F, Naemi A. The effectiveness of self-forgiveness training with a religious approach on vitality and failure tolerance of mothers of children with intellectual and developmental disabilities. J Modern Psychol Res. 2019;13(52):305-26. Persian. https://psychologyj.tabrizu.ac.ir/article_8636.html?lang=en
20. Rahimi N, Afsharinia K. Prediction of psychological resilience based on degree of differentiation and frustration tolerance in the elderly. Aging Psychol. 2017;3(2):127-36. [Persian]. https://jap.razi.ac.ir/article_761.html?lang=en
21. Yu S, Mao S, Wu AMS. The interplay among stress, frustration tolerance, mindfulness, and social support in Internet gaming disorder symptoms among Chinese working adults. Asia Pac Psychiatr. 2018;10(4):e12319. doi.10.1111/appy.12319. [
DOI:10.1111/appy.12319] [
PMID]
22. Ramirez-Castillo D, Garcia-Roda C, Guell F, Fernandez-Montalvo J, Bernacer J, Morón I. Frustration tolerance and personality traits in patients with substance use disorders. Front Psychiatr. 2019;1-12. [
DOI:10.3389/fpsyt.2019.00421] [
PMID] [
PMCID]
23. Berkowitz L. A cognitive-neoassociation theory of aggression. The handbook of theories of social psychology. Sage Publications Ltd. 2012;99-117p. https://psycnet.apa.org/doi/10.4135/9781446249222.n31 [
DOI:10.4135/9781446249222.n31]
24. Amiri M, Sadeghi Z, Sadeghi E, Khosravi A. Relationship between assertion and aggression with addiction potential: a cross-sectional study in 2019. Osong Public Health Res Perspect. 2020;11(4):231. doi. 10.24171/j.phrp.2020.11.4.12. [
DOI:10.24171/j.phrp.2020.11.4.12] [
PMID] [
PMCID]
25. Akçay BD, Akçay D. What are the factors that contribute to aggression in patients with co-occurring antisocial personality disorder and substance abuse? Arch Clin Psychiatr. 2020;47(4):95-100. doi. 10.1590/0101-60830000000240. [
DOI:10.1590/0101-60830000000240]
26. Safari F. Addiction and women gender differences concerning drug abuse and its treatment. Res addict. 2003;1(2):119-39. [Persian]. http://etiadpajohi.ir/article-1-492-fa.html.
27. Wilson Van Voorhis CR, Morgan BL. Understanding power and rules of thumb for determining sample size. Tutor Quant Methods Psychol. 2007;3(2):43‐50. doi.10.20982/tqmp.03.2.p043. [
DOI:10.20982/tqmp.03.2.p043]
28. Melzak R. (1975). The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1(3):277-99. doi. 10.1016/0304-3959(75)90044-5. [
DOI:10.1016/0304-3959(75)90044-5]
29. Kosravi M, Sadighi S, Moradi Alamdari Sh, Zendehdel K. Persian-McGill pain questionnaire translation, adaptation and reliability in cancer patients: a brief report. Tehran Univ Med. 2013;71(1):53-8. [Persian]. http://tumj.tums.ac.ir/article-1-38-fa.html.
30. Samani S. Study of Reliability and Validity of the Buss and Perry's Aggression Questionnaire. IJPCP. February 2008;13(4):359-365. Persian. http://ijpcp.iums.ac.ir/article-1-356-fa.html.
31. Harrington, N. The frustration discomfort scale: Development and psychometric properties. Clin Psychol Psychother. 2005; 12(5):374-387. doi.org/10.1002/cpp.465. [
DOI:10.1002/cpp.465]
32. Babaraisi, MA. Validation of Failure Tolerance Questionnaire. Tehran: Azmoon Yarpouya. 2014. Persian. http://www.azmonyar.com/Pro002.aspx
33. Buss AH, Perry M. The aggression questionnaire. J Pers Soc Psychol. 1992;63:452-9. doi. 10.1037//0022-3514.63.3.452. [
DOI:10.1037/0022-3514.63.3.452] [
PMID]
34. Najarian B, Davoodi I. Construction and validation of SCL-25 (short-term form SCL-90-R). J Psychol. 2002;5(2):136-49. Persian. https://www.sid.ir/fa/journal/ViewPaper.aspx?id=27176
35. Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJ. Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacolo. 2021;46:1715-23. https://www.nature.com/articles/s41386-020-00950-y [
DOI:10.1038/s41386-020-00950-y] [
PMID] [
PMCID]
36. Compton P, Charuvastra VC, Kintaudi K, Ling W. Pain responses in methadon-maintained opioid abusers. J Pain Sym Manag. 2000;20(4):237-45. doi. 10.1016/s0885-3924(00)00191-3. [
DOI:10.1016/S0885-3924(00)00191-3]
37. Wiesenfeld-Hallin, Z. Sex differences in pain perception. Gend Med. 2005;2(3):137-45. doi. 10.1016/s1550-8579(05)80042-7. [
DOI:10.1016/S1550-8579(05)80042-7]
38. Pieretti S, Di Giannuario A, Di Giovannandera, R, Marzoli F, Piccaro G, Minosi P, Aloisi AM. Gender differences in pain and its relief. Ann Ist Super Sanita. 2016;52(2):184-9. doi. 10.4415/ANN_16_02_09.
39. Lee CW, Ho IK. Sex differences in opioid analgesia and addiction: interactions among opioid receptors and estrogen receptors. Mol Pain. 2013;8(9):45. doi.10.1186/1744-8069-9-45. [
DOI:10.1186/1744-8069-9-45] [
PMID] [
PMCID]
40. Chiang YC, Wang RY, Huang CL, Chen SH, Ho WJ et al. Reduced dosing and liability in methadone maintenance treatment by targeting estrogen signal for morphine addiction. J Cell Mol Med. 2017;21(12):3552-64. doi. 10.1111/jcmm.13266. [
DOI:10.1111/jcmm.13266] [
PMID] [
PMCID]
41. Jebraeili H, Habibi M, Nazemi A. Mediating role of resilience and tendency to addiction regarding the effect of gender on substance use. J Res Health. 2019;9(3):236-45. [Persian]. http://dx.doi.org/10.29252/jrh.9.3.236 [
DOI:10.29252/jrh.9.3.236]
42. Corr PJ. Testing problems in JA, Gray's personality theory: A commentary on Matthews and Gilliland (1999). Person Individ Differ. 2001;30(2): 333-52. doi.org/10.1016/S0191-8869(00)00028-3. [
DOI:10.1016/S0191-8869(00)00028-3]
43. Muñoz-Reyes JA, Polo P, Valenzuela N, Pavez P, Ramirez-Herrera O, Figueroa O, Rodrigez-Sickert c, Diaz D, Pita M. The Male Warrior Hypothesis: Testosterone-related Cooperation and Aggression in the Context of Intergroup Conflict. Sci Rep. 2020; 10:375. doi.org/10.1038/s41598-019-57259-0 [
DOI:10.1038/s41598-019-57259-0] [
PMID] [
PMCID]